Centro di riferimento Oncologico di Aviano

Aviano 33081

2 studies enrolling now · 9 studies all time

What they study most

Biliary Tract Cancer, Early Breast Cancer, Indolent Non-Hodgkin's Lymphomas, Locally Advanced or Metastatic Unresectable Urothelial Cancer, Lymphoma, B-cell, Lymphoma, Large B-cell, Diffuse, Metastatic Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Ovarian Cancer, Small-cell Lung Cancer

Studies at this site

• Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression — Recruiting now
• Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients — Recruiting now
• Study of Sacituzumab Govitecan Versus Physician's Choice of Treatment in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread — Completed
• Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus CAV or Topotecan as Treatment in Patients With Small-Cell Lung Cancer — Completed
• A Comparison of Intra-operative Radiotherapy Boost With External Beam Radiotherapy Boost in Early Breast Cancer. — Status unconfirmed
• Efficacy and Safety of Idelalisib (GS-1101) in Combination With Bendamustine and Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas — Stopped early
• Study of Brentuximab Vedotin Combined With RCHOP or RCHP in Front-line Treatment of Patients With Diffuse Large B-cell Lymphoma (DLBCL) — Stopped early
• IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma — Completed
• XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors — Stopped early